Title:
USE OF TELLURIUM COMPOUNDS FOR INHIBITION OF INTERLEUKIN-CONVERTING ENZYME
Document Type and Number:
WIPO Patent Application WO2006030438
Kind Code:
A3
Abstract:
Use of tellurium-containing compounds for treating conditions in which inhibition of caspase-1/interleukin-1 ß enzyme (ICE) is beneficial is disclosed.
Inventors:
ALBECK MICHAEL (IL)
SREDNI BENJAMIN (IL)
SREDNI BENJAMIN (IL)
Application Number:
PCT/IL2005/000990
Publication Date:
May 04, 2006
Filing Date:
September 15, 2005
Export Citation:
Assignee:
BIOMAS LTD (IL)
ALBECK MICHAEL (IL)
SREDNI BENJAMIN (IL)
ALBECK MICHAEL (IL)
SREDNI BENJAMIN (IL)
International Classes:
A61K31/335
Foreign References:
| US4752614A | 1988-06-21 | |||
| US4761490A | 1988-08-02 | |||
| US4929739A | 1990-05-29 | |||
| US4962207A | 1990-10-09 | |||
| US5093135A | 1992-03-03 | |||
| US5102908A | 1992-04-07 |
Other References:
KALECHMAN Y. ET AL: "Up-Regulation by Ammonium Trichloro(Dioxoethylene-0,0') Tellurate (AS101) of Fas/Apo-1 Expression on B16 Melanoma Cells: Implications for the antitumor Effects of AS101", JOURNAL OF IMMUNOLOGY, vol. 161, no. 7, October 1998 (1998-10-01), pages 3536 - 3542, XP002995790
Download PDF:
Previous Patent: NOVEL TELLURIUM COMPOUNDS AND THEIR USE AS IMMUNOMODULATORS
Next Patent: COMPOSITIONS AND METHODS FOR INDUCING HAIR GROWTH
Next Patent: COMPOSITIONS AND METHODS FOR INDUCING HAIR GROWTH